Compare Novavax Inc (NVAX) vs PayPal Holdings, Inc. (PYPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs PayPal Holdings, Inc. — how do they compare? Novavax Inc trades at $12.75 (market cap $1.82B), while PayPal Holdings, Inc. trades at $55.53 (market cap $47.07B). The key difference: PayPal Holdings, Inc. is far larger — about 25.9× Novavax Inc's market cap, and PayPal Holdings, Inc. pays a 1.02% dividend while Novavax Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Novavax Inc for 59 Days and PayPal Holdings, Inc. for 106 Days on average.
| NVAX | PYPL | |
|---|---|---|
Market Cap | $1.82B | $47.07B |
Volume | 6,198,505 | 13,860,099 |
Sector | Health | Financials |
52-Week High | $12.75 | $73.01 |
52-Week Low | $6.22 | $39.08 |
Typical Hold Time | 59 Days | 106 Days |
Enterprise Value | $1.39B | $49.21B |
Dividend Yield | — | 1.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $11.01, down 1.87% on the day, with a bullish technical signal from moving averages and a strong buy consensus from analysts (73.9% buy ratings). The company reported a net income of $440.3M in 2025, a significant turnaround from prior losses, though 2026 projections show a return to negative margins. Recent news highlights regulatory approvals for its COVID-19 vaccine and strategic pivots toward its Matrix-M adjuvant platform through partnerships.
The outlook is mixed: near-term catalysts include partnership-driven growth and vaccine approvals, but persistent cash burn and projected 2026 losses pose risks. Investor sentiment is buoyed by recent earnings beats and strategic shifts, yet execution on profitability remains critical for sustained upside.
PayPal trades at $55.02, up 0.13% with a bullish technical signal from moving averages. The stock shows strong fundamentals with a P/E of 10.4, net margin of 14.36%, and recent earnings beats. Recent partnerships with Meta and cost-cutting initiatives under new CEO Enrique Lores are driving positive sentiment. Cash flow remains healthy with $1.53B net cash flow in 2025.
PayPal presents a value opportunity with attractive valuation metrics and improving operational efficiency. Key risks include checkout competition and slowing growth in branded solutions. Analyst consensus leans cautious with 60% hold ratings, though the $56.41 price target suggests modest upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About PayPal Holdings, Inc.
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →
